Food Supplement Physiomanna® Baby in Pediatric Patients

Inclusion Criteria: * Male or female outpatients between the ages of 0 to 8 years; * Functional constipation according to ROME III criteria (Annex 2); * Two or fewer SBM during the previous week; SBM is defined as BM not preceded after a 24 h administration with a laxative or enema; * To be otherwise in good health, as judged by a physical examination; * Mentally competent parent or tutor to sign an informed consent Exclusion Criteria: * Known history of organic cause for the constipation; * Congenital malformations that produce constipation (Hirschsprung's disease, imperforate anus, children with cerebral palsy or other neurologic abnormalities, or systemic diseases); * Fecal Occult Blood Test (FOBT) positive in the 4 previous weeks; * Fecal impaction at baseline, or during the trial period, as indicated by the physical examination; * Known or suspected perforation or obstruction other than fecal impaction; * History of gastric retention, inflammatory bowel disease, bowel resection, or colostomy; * Use of concomitant medications that cause constipation in the previous 3 months; * Concomitant use of herbs and other dietary supplements, such as: stimulant laxative herbs and/or potassium depleting herbs; * Concomitant use of cardiac glycosides(e.g. Digoxin); * Patients who, according to the investigator, should not be included in the study for any reason, including the parent's inability to follow the study procedures; * Patients with known allergy to Fraxinus Manna, mannitole, fennel, lemon balm or chamomile; * Patients with clinically significant elevations of TSH or abnormal plasma electrolytes in the 4 previous weeks; * Patients who, within the past 30 days have participated in an investigational clinical study;